Glycated Hemoglobin as A Marker for Predicting Outcomes of Patients with Hemorrhagic Stroke

Moid Khan; Mazhar Badshah; Ahmed Hussain; Najeeb Khan; Faiz Khan; Nabeel Tariq

doi:10.70749/ijbr.v3i7.1799

Authors

Moid Khan Department of Neurology, PIMS Hospital, Islamabad, Pakistan.
Mazhar Badshah Department of Neurology, PIMS Hospital, Islamabad, Pakistan.
Ahmed Hussain Department of Neurology, PIMS Hospital, Islamabad, Pakistan.
Najeeb Khan Department of Neurology, PIMS Hospital, Islamabad, Pakistan.
Faiz Khan Department of Neurology, PIMS Hospital, Islamabad, Pakistan.
Nabeel Tariq Department of Neurology, PIMS Hospital, Islamabad, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i7.1799

Keywords:

Hemorrhagic Stroke, Glycated Hemoglobin (HbA1c), Stroke Outcomes, Diabetes Mellitus, Neurological Recovery

Abstract

Background: A severe cerebrovascular event with a high morbidity and fatality rate is hemorrhagic stroke (HS). Finding trustworthy prognostic indicators is essential to enhancing clinical results. Glycated hemoglobin (HbA1c), which has been connected to vascular dysfunction and the risk of stroke, is a measure of long-term glycemic management. Its predictive usefulness for hemorrhagic stroke outcomes is still unknown, though. Objective: This study aims to evaluate the role of HbA1c as a predictive biomarker for clinical outcomes in patients with hemorrhagic stroke, focusing on stroke severity, functional recovery, and mortality. Methods: At Quetta's Bolan Medical Complex Hospital, 300 patients with hemorrhagic stroke were the subjects of a prospective observational study. Based on their HbA1c readings, patients were divided into three groups: <5.7%, 5.7%–6.4%, and >6.5%. The Glasgow Coma Scale (GCS) and NIH Stroke Scale (NIHSS) were used to measure clinical severity. The modified Rankin Scale (mRS) was used to assess functional outcomes both at discharge and ninety days after the stroke. Independent predictors of unfavorable outcomes were found using logistic regression analysis. Results: Significantly negative outcomes were seen by patients with HbA1c >6.5%, including higher mean blood pressure (160/95 mmHg ± 14, p=0.001), higher NIHSS scores (14.7 ± 5.2, p=0.002), and lower GCS scores (8.9 ± 3.2, p=0.001). This group had the lowest functional independence (18.2%, p=0.001) and the highest mortality (36.4%, p=0.002). Along with age >60 years, hypertension, and high NIHSS scores, logistic regression verified that HbA1c >6.5% was an independent predictor of poor functional recovery (OR: 2.9, p=0.001). Conclusion: In hemorrhagic stroke patients, elevated HbA1c levels are linked to worse functional recovery, higher mortality, and more severe stroke. A major independent predictor of unfavorable outcomes is a HbA1c >6.5%. These results imply that regular HbA1c testing could help patients with hemorrhagic stroke with risk assessment and clinical decision-making.

Downloads

Download data is not yet available.

References

Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2017). IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Research and Clinical Practice, 128, 40–50.

https://doi.org/10.1016/j.diabres.2017.03.024

Roglic G. (2016). World Health Organization eds. Global report on diabetes. Geneva, Switzerland: World Health Organization.

Tun, N. N., Arunagirinathan, G., Munshi, S. K., & Pappachan, J. M. (2017). Diabetes mellitus and stroke: A clinical update. World Journal of Diabetes, 8(6), 235.

https://doi.org/10.4239/wjd.v8.i6.235

Beckman, J. A., Paneni, F., Cosentino, F., & Creager, M. A. (2013). Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: part II. European Heart Journal, 34(31), 2444-2452.

https://doi.org/10.1093/eurheartj/eht142

Lau, L., Lew, J., Borschmann, K., Thijs, V., & Ekinci, E. I. (2018). Prevalence of diabetes and its effects on stroke outcomes: A meta‐analysis and literature review. Journal of Diabetes Investigation, 10(3), 780-792.

https://doi.org/10.1111/jdi.12932

O'Donnell, M. J., Chin, S. L., Rangarajan, S., Xavier, D., Liu, L., Zhang, H., Rao-Melacini, P., Zhang, X., Pais, P., Agapay, S., Lopez-Jaramillo, P., Damasceno, A., Langhorne, P., McQueen, M. J., Rosengren, A., Dehghan, M., Hankey, G. J., Dans, A. L., Elsayed, A., … Yusuf, S. (2016). Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. The Lancet, 388(10046), 761-775.

https://doi.org/10.1016/s0140-6736(16)30506-2

Eriksson, M., Carlberg, B., & Eliasson, M. (2012). The disparity in long-term survival after a first stroke in patients with and without diabetes persists: The northern Sweden MONICA study. Cerebrovascular Diseases, 34(2), 153-160.

https://doi.org/10.1159/000339763

Piernik-Yoder, B., & Ketchum, N. (2013). Rehabilitation outcomes of stroke patients with and without diabetes. Archives of Physical Medicine and Rehabilitation, 94(8), 1508-1512.

https://doi.org/10.1016/j.apmr.2013.04.014

Li, H., Yang, M., & Chung, K. (2011). Predictors for readmission of acute ischemic stroke in Taiwan. Journal of the Formosan Medical Association, 110(10), 627-633.

https://doi.org/10.1016/j.jfma.2011.08.004

Papazafiropoulou, A., Tentolouris, N., Bousboulas, S., Sotiropoulos, A., Tamvakos, E., Peppas, T., Kardara, M., & Pappas, S. (2010). In-hospital mortality in a tertiary referral hospital: Causes of death and comparison between patients with and without diabetes. Experimental and Clinical Endocrinology & Diabetes, 118(05), 315-319.

https://doi.org/10.1055/s-0029-1241215

Ripley, D. L., Seel, R. T., Macciocchi, S. N., Schara, S. L., Raziano, K., & Ericksen, J. J. (2007). The impact of diabetes mellitus on stroke acute rehabilitation outcomes. American Journal of Physical Medicine & Rehabilitation, 86(9), 754-761.

https://doi.org/10.1097/phm.0b013e31813e0769

Tuttolomondo, A., Pinto, A., Salemi, G., Di Raimondo, D., Di Sciacca, R., Fernandez, P., Ragonese, P., Savettieri, G., & Licata, G. (2008). Diabetic and non-diabetic subjects with ischemic stroke: Differences, subtype distribution and outcome. Nutrition, Metabolism and Cardiovascular Diseases, 18(2), 152-157.

https://doi.org/10.1016/j.numecd.2007.02.003

D'Emden, M. C., Shaw, J. E., Colman, P. G., Colagiuri, S., Twigg, S. M., Jones, G. R., Goodall, I., Schneider, H. G., & Cheung, N. W. (2012). The role of HbA1c in the diagnosis of diabetes mellitus in Australia. Medical Journal of Australia, 197(4), 220-221.

https://doi.org/10.5694/mja12.10988

Mackey, P. A., & Whitaker, M. D. (2015). Diabetes mellitus and hyperglycemia management in the hospitalized patient. The Journal for Nurse Practitioners, 11(5), 531-537.

https://doi.org/10.1016/j.nurpra.2015.02.016

Khan, H. A., Sobki, S. H., & Khan, S. A. (2007). Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia. Clinical and Experimental Medicine, 7(1), 24-29.

https://doi.org/10.1007/s10238-007-0121-3

Sherwani, S. I., Khan, H. A., Ekhzaimy, A., Masood, A., & Sakharkar, M. K. (2016). Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker Insights, 11, BMI.S38440.

https://doi.org/10.4137/bmi.s38440

Kranenburg, G., Van der Graaf, Y., Van der Leeuw, J., Nathoe, H. M., De Borst, G. J., Kappelle, L. J., Visseren, F. L., & Westerink, J. (2015). The relation between HbA1c and cardiovascular events in patients with type 2 diabetes with and without vascular disease. Diabetes Care, 38(10), 1930-1936.

https://doi.org/10.2337/dc15-0493

Wang, J., Li, Q., & Liu, J. (2020). Prognostic factors in spontaneous intracerebral hemorrhage: A systematic review. World Neurosurgery, 140, e67–e77. https://doi.org/10.1016/j.wneu.2020.04.063

American Diabetes Association. (2022). Diagnosis and classification of diabetes mellitus. Diabetes Care, 45(Suppl 1), S17–S38.

https://doi.org/10.2337/dc22-S002

Kim, Y. H., Her, A., Jeong, M. H., Kim, B., Hong, S., Kim, S., Ahn, C., Kim, J., Ko, Y., Choi, D., Hong, M., & Jang, Y. (2020). Effect of renin-angiotensin system inhibitors on major clinical outcomes in patients with acute myocardial infarction and prediabetes or diabetes after successful implantation of newer-generation drug-eluting stents. Journal of Diabetes and its Complications, 34(6), 107574.

https://doi.org/10.1016/j.jdiacomp.2020.107574

Zhang, X., Yang, Y., & Lin, Y. (2021). Glycemic variability and hemorrhagic stroke prognosis: A prospective study. Journal of Stroke, 23(3), 419–428.

https://doi.org/10.5853/jos.2021.00999

Zhang, G., He, M., Xu, Y., Li, X., Cai, Z., Guo, Z., Meng, P., Ji, N., He, X., & Pang, L. (2018). Hemoglobin A1c predicts hemorrhagic transformation and poor outcomes after acute anterior stroke. European Journal of Neurology, 25(12), 1432.

https://doi.org/10.1111/ene.13747

Kang, K., Lu, J., Ju, Y., Wang, W., Shen, Y., Wang, A., Cao, Z., & Zhao, X. (2019). Association of pre- and post-stroke glycemic status with clinical outcome in spontaneous intracerebral hemorrhage. Scientific Reports, 9(1).

https://doi.org/10.1038/s41598-019-55610-z

Jafar, N., Braksick, S. A., Rabinstein, A. A., & Rabinstein, A. A. (2021). Glycated Hemoglobin as a Marker for Predicting Outcomes of Patients With Stroke (Ischemic and Hemorrhagic): A Systematic Review and Meta-Analysis. Frontiers in Neurology, 12, 666919.

https://doi.org/10.3389/fneur.2021.666919

Sung, J. Y., Chen, C. I., Hsieh, Y. C., Chen, Y. R., Wu, H. C., Chan, L., Hu, C. J., Hu, H. H., Chiou, H. Y., & Chi, N. F. (2017). Comparison of admission random glucose, fasting glucose, and glycated hemoglobin in predicting the neurological outcome of acute ischemic stroke: a retrospective study. PeerJ, 5, e2948–e2948.

https://doi.org/10.7717/peerj.2948

Sunaga, K., Miura, K., Naruse, Y., Sakurai, M., Morikawa, Y., Kurosawa, Y., & Nakagawa, H. (2008). Glycated hemoglobin and risk of stroke, ischemic and hemorrhagic, in Japanese men and women. Cerebrovascular Diseases, 26(3), 310-316.

https://doi.org/10.1159/000149579